Compare PBHC & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBHC | BEAT |
|---|---|---|
| Founded | 1859 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 63.5M |
| IPO Year | N/A | 2021 |
| Metric | PBHC | BEAT |
|---|---|---|
| Price | $14.89 | $2.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 3.5K | ★ 30.8M |
| Earning Date | 01-30-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $44,154,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.86 | ★ N/A |
| Revenue Growth | ★ 24.40 | N/A |
| 52 Week Low | $13.50 | $0.54 |
| 52 Week High | $17.92 | $3.48 |
| Indicator | PBHC | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 74.82 |
| Support Level | $13.92 | $0.66 |
| Resistance Level | $14.90 | $2.82 |
| Average True Range (ATR) | 0.48 | 0.26 |
| MACD | 0.07 | 0.18 |
| Stochastic Oscillator | 95.86 | 75.67 |
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.